Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real‐world data

• Principais autores: Yoshiteru Takekita (Autor), Shuichi Hiraoka (Autor), Yasuhiro Iwama (Autor), Daisuke Matsui (Autor), Nobuatsu Aoki (Autor), Haruhiko Ogata (Autor), Toshiya Funatsuki (Autor), Toshiyuki Shimizu (Autor), Yuji Murase (Autor), Yosuke Koshikawa (Autor), Masaki Kato (Autor), Toshihiko Kinoshita (Autor)
• Formato: Livro
• Publicado em: Wiley, 2024-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Aims A meta‐analysis of short‐term studies revealed no significant differences between the doses of asenapine, 10 and 20 mg/day, in the acute treatment of schizophrenia. However, it should be noted that many patients from clinical practice were excluded, and the dose-response to asenapine i...